Payloads for Antibody–Drug Conjugates

ADVERTISEMENT RETURN TO ISSUEEditorialNEXTPayloads for Antibody–Drug ConjugatesWilliam R. F. GoundryWilliam R. F. GoundryEarly Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K.More by William R. F. Goundryhttps://orcid.org/0000-0003-2869-5855 and Jeremy S. Parker*Jeremy S. ParkerEarly Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K.*Email: [email protected]More by Jeremy S. Parkerhttps://orcid.org/0000-0002-4758-3181Cite this: Org. Process Res. Dev. 2022, 26, 8, 2121–2123Publication Date (Web):August 19, 2022Publication History Received19 July 2022Published online19 August 2022Published inissue 19 August 2022https://doi.org/10.1021/acs.oprd.2c00227Copyright © Published 2022 by American Chemical SocietyRIGHTS & PERMISSIONSArticle Views4256Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (992 KB) Get e-AlertsSUBJECTS:Biopolymers,Cancer,Molecules,Peptides and proteins,Toxicity Get e-Alerts